SilkTears

Maple Grove, United States

Protein eye drop developer for ocular surface diseases

$3.6M raised

Sep 2023

Seed

Top Investors

Skyview Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has SilkTears raised?

SilkTears has raised $3.6M in total funding. The most recent round was Seed. The last funding was announced in September 2023.

Who are SilkTears's investors?

SilkTears's investors include Skyview Capital.

Where is SilkTears headquartered?

SilkTears is headquartered in Maple Grove, United States.

What does SilkTears do?

Protein eye drop developer for ocular surface diseases

What stage is SilkTears at?

SilkTears is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 1, 2023.

MLA

"SilkTears — Funding & Investors." VCBacked, September 1, 2023, https://www.vcbacked.co/company/silktears. Accessed June 17, 2026.

APA

VCBacked. (2023). SilkTears — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/silktears

Wikipedia (cite web)

{{cite web |title=SilkTears — Funding & Investors |url=https://www.vcbacked.co/company/silktears |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 1, 2023.